HPV, or human papillomavirus, is linked to several types of cancer, including cervical, anal, and throat cancers. India’s HPV vaccine market was worth ₹91 crore as of January 2026, on a moving annual total basis, according to pharma intelligence platform Pharmarack.
HPV vaccines gain traction in India, though cost keeps reach limited
📅 Published: February 10, 2026 |
📂 Category: Uncategorized
